Insider · CIK 0001781149

Kiely John

Reports to the SEC for 2 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001781149

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-13	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−50K sh	$17.64	−$882K	210,252
2026-08-13	AMRXAmneal Pharmaceuticals, Inc.G Gift	Director	GGift	−10K sh	—	—	200,252
2026-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.8K sh	—	—	260,252
2026-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.8K sh	—	—	0
2026-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.8K sh	—	—	19,824
2025-08-27	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−32K sh	$9.23	−$295K	225,433
2025-05-12	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−50K sh	$7.59	−$380K	257,433
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	307,433
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2024-11-22	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+28.5K sh	$4.76	+$136K	284,233
2024-11-22	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−17.1K sh	$8.38	−$143K	267,175
2024-11-22	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−28.5K sh	—	—	0
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	255,727
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2023-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+80.1K sh	—	—	179,274
2023-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−80.1K sh	—	—	0
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2022-08-31	Zovio IncM Exercise/Conversion	Director	MExercise/Conversion	+8,855 sh	—	—	71,865
2022-08-31	Zovio IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+8,855 sh	—	—	8,855
2022-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+80.1K sh	—	—	80,128
2022-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.4K sh	—	—	99,146
2022-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.4K sh	—	—	0
2022-03-29	Zovio IncM Exercise/Conversion	Director	MExercise/Conversion	+16.4K sh	—	—	63,010
2022-03-29	Zovio IncRestricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−16.4K sh	—	—	0
2022-03-29	Zovio IncRestricted Stock UnitA Award	Director	AAward	+18.9K sh	—	—	18,890
2021-08-31	Zovio IncM Exercise/Conversion	Director	MExercise/Conversion	+8,855 sh	—	—	46,600
2021-08-31	Zovio IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,855 sh	—	—	17,710
2021-05-06	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+46.2K sh	—	—	63,740
2021-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−46.2K sh	—	—	0
2021-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+35.4K sh	—	—	35,406
2021-03-29	Zovio IncM Exercise/Conversion	Director	MExercise/Conversion	+18.9K sh	—	—	37,745
2021-03-29	Zovio IncRestricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−18.9K sh	—	—	0
2021-03-29	Zovio IncRestricted Stock UnitA Award	Director	AAward	+16.4K sh	—	—	16,410
2020-12-15	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,522 sh	—	—	17,522
2020-12-15	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,522 sh	—	—	0
2020-09-08	Zovio IncP Purchase	Director	PPurchase	+10K sh	$4.26	+$42.6K	18,855
2020-08-31	Zovio IncM Exercise/Conversion	Director	MExercise/Conversion	+8,855 sh	—	—	8,855
2020-08-31	Zovio IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,855 sh	—	—	26,565
2020-05-19	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+10K sh	$4.40	+$44K	10,000
2020-05-12	Zovio IncRestricted Stock UnitA Award	Director	AAward	+18.9K sh	—	—	18,890
2020-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+46.2K sh	—	—	46,218
2019-12-14	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+28.5K sh	—	—	28,506
2019-12-14	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+7,522 sh	—	—	7,522
2019-08-31	Zovio IncRestricted Stock UnitA Award	Director	AAward	+35.4K sh	—	—	35,420

Recent filings

Accepted (ET)
Aug 144
Kiely John0001628280-26-057147
SEC(opens sec.gov)
May 84
Kiely John0001628280-26-032911
SEC(opens sec.gov)
Aug 284
Kiely John0001781149-25-000006
SEC(opens sec.gov)
May 134
Kiely John0001628280-25-025140
SEC(opens sec.gov)
May 84
Kiely John0001628280-25-023991
SEC(opens sec.gov)
Nov 264
Kiely John0001628280-24-049297
SEC(opens sec.gov)
May 144
Kiely John0001628280-24-023252
SEC(opens sec.gov)
May 64
Kiely John0001628280-24-020735
SEC(opens sec.gov)
May 114
Kiely John0001209191-23-028735
SEC(opens sec.gov)
Sep 24
Kiely John0001567619-22-017003
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807